| Targeting folate receptor alpha for cancer treatment A Cheung, HJ Bax, DH Josephs, KM Ilieva, G Pellizzari, J Opzoomer, ... Oncotarget 7 (32), 52553, 2016 | 278 | 2016 |
| IgG4 subclass antibodies impair antitumor immunity in melanoma P Karagiannis, AE Gilbert, DH Josephs, N Ali, T Dodev, L Saul, I Correa, ... The Journal of clinical investigation 123 (4), 1457-1474, 2013 | 180 | 2013 |
| Upregulation of the CD40/CD40 ligand dyad and platelet-monocyte aggregation in cigarette smokers SA Harding, J Sarma, DH Josephs, NL Cruden, JN Din, PJ Twomey, ... Circulation 109 (16), 1926-1929, 2004 | 158 | 2004 |
| Combining immune checkpoint inhibitors: established and emerging targets and strategies to improve outcomes in melanoma DO Khair, HJ Bax, S Mele, S Crescioli, G Pellizzari, A Khiabany, ... Frontiers in immunology 10, 453, 2019 | 155 | 2019 |
| Regional activation of myosin II in cancer cells drives tumor progression via a secretory cross-talk with the immune microenvironment M Georgouli, C Herraiz, E Crosas-Molist, B Fanshawe, O Maiques, ... Cell 176 (4), 757-774. e23, 2019 | 93 | 2019 |
| Clinical pharmacokinetics of tyrosine kinase inhibitors: implications for therapeutic drug monitoring DH Josephs, DS Fisher, J Spicer, RJ Flanagan Therapeutic drug monitoring 35 (5), 562-587, 2013 | 87 | 2013 |
| A tool kit for rapid cloning and expression of recombinant antibodies TS Dodev, P Karagiannis, AE Gilbert, DH Josephs, H Bowen, LK James, ... Scientific reports 4 (1), 1-10, 2014 | 86 | 2014 |
| Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs) RM Hoffmann, BGT Coumbe, DH Josephs, S Mele, KM Ilieva, A Cheung, ... Oncoimmunology 7 (3), e1395127, 2018 | 85 | 2018 |
| Epidemiological associations of allergy, IgE and cancer DH Josephs, JF Spicer, CJ Corrigan, HJ Gould, SN Karagiannis Clinical & Experimental Allergy 43 (10), 1110-1123, 2013 | 84 | 2013 |
| Effects of BRAF Mutations and BRAF Inhibition on Immune Responses to MelanomaBRAF Mutations and Immunity in Melanoma KM Ilieva, I Correa, DH Josephs, P Karagiannis, IU Egbuniwe, ... Molecular cancer therapeutics 13 (12), 2769-2783, 2014 | 80 | 2014 |
| An automated method for the measurement of a range of tyrosine kinase inhibitors in human plasma or serum using turbulent flow liquid chromatography–tandem mass spectrometry L Couchman, M Birch, R Ireland, A Corrigan, S Wickramasinghe, ... Analytical and Bioanalytical Chemistry 403 (6), 1685-1695, 2012 | 77 | 2012 |
| BRAF inhibitors: resistance and the promise of combination treatments for melanoma M Griffin, D Scotto, DH Josephs, S Mele, S Crescioli, HJ Bax, G Pellizzari, ... Oncotarget 8 (44), 78174, 2017 | 74 | 2017 |
| Monitoring the systemic human memory B cell compartment of melanoma patients for anti-tumor IgG antibodies AE Gilbert, P Karagiannis, T Dodev, A Koers, K Lacy, DH Josephs, ... PloS one 6 (4), e19330, 2011 | 64 | 2011 |
| AllergoOncology–the impact of allergy in oncology: EAACI position paper E Jensen‐Jarolim, HJ Bax, R Bianchini, M Capron, C Corrigan, M Castells, ... Allergy 72 (6), 866-887, 2017 | 62 | 2017 |
| Tumour-associated macrophage polarisation and re-education with immunotherapy DH Josephs, HJ Bax, SN Karagiannis Front Biosci (Elite Ed) 7, 293-308, 2015 | 60 | 2015 |
| Molecular imaging in clinical trials D Josephs, J Spicer, M O’Doherty Targeted oncology 4 (3), 151-168, 2009 | 59 | 2009 |
| Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with severe renal impairment or on haemodialysis D Josephs, TE Hutson, CL Cowey, LM Pickering, JM Larkin, ME Gore, ... BJU international 108 (8), 1279-1283, 2011 | 57 | 2011 |
| Recombinant IgE antibodies for passive immunotherapy of solid tumours: from concept towards clinical application SN Karagiannis, DH Josephs, P Karagiannis, AE Gilbert, L Saul, ... Cancer Immunology, Immunotherapy 61 (9), 1547-1564, 2012 | 56 | 2012 |
| Factors affecting COVID-19 outcomes in cancer patients: a first report from guy's cancer center in London B Russell, C Moss, S Papa, S Irshad, P Ross, J Spicer, S Kordasti, ... Frontiers in oncology 10, 1279, 2020 | 54 | 2020 |
| Anti-folate receptor alpha–directed antibody therapies restrict the growth of triple-negative breast cancer A Cheung, J Opzoomer, KM Ilieva, P Gazinska, RM Hoffmann, H Mirza, ... Clinical Cancer Research 24 (20), 5098-5111, 2018 | 53 | 2018 |
Sophia N KaragiannisProfessor of Translational Cancer Immunology and Immunotherapy, King’s College LondonDirección de correo verificada de kcl.ac.uk
